My Gene Counsel
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • BIOPHARMA, CLINICAL TRIALS & PAYERS
  • Solutions
    • My Gene Screen
    • Living Lab Reports
    • Genetic Alerts
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

by Danielle Bonadies | Dec 29, 2020 | Press Releases

With transformative digital technologies playing an increasingly critical role in health care delivery, the two companies have joined forces on a digital genomic solution that will increase efficiencies and outcomes within the highly specialized space of oncology. NEW...
Tumor Testing: Finding the Right Key for Your Lock

Tumor Testing: Finding the Right Key for Your Lock

by Danielle Bonadies | Nov 12, 2020 | Genetic Journal

November is Lung Cancer Awareness Month. According to the Centers for Disease Control and Prevention (CDC), lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States. On top of those jarring...
Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

by Danielle Bonadies | Jun 26, 2020 | Publications

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

by Danielle Bonadies | Jun 1, 2020 | Multimedia

GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing. This case-based discussion will...
Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

by Danielle Bonadies | Feb 6, 2020 | News

Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...

Recent Posts

  • Genetic Testing Challenges in Precision Medicine: Lab Fails to Report NF2 Mosaic Variant
  • Career Compass: Tips and Tricks for Second Year Students and Recent Graduates with Christina Frater
  • Continuing Education Opportunities
  • ABGC Boards Resources
  • The Speed and Scope of Genetic Updates | My Gene Counsel

Archives

  • About Us
  • Media
  • Genetic Journal Blog
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • Biopharma, Clinical Trials & Payers
  • My Gene Screen
  • Living Lab Reports®
  • Genetic Alerts
  • Contact Us
  • FAQs
  • Career Resources

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©